MC200059A1 - Formulation à délai d'action rapide - Google Patents

Formulation à délai d'action rapide

Info

Publication number
MC200059A1
MC200059A1 MC2486A MC2486A MC200059A1 MC 200059 A1 MC200059 A1 MC 200059A1 MC 2486 A MC2486 A MC 2486A MC 2486 A MC2486 A MC 2486A MC 200059 A1 MC200059 A1 MC 200059A1
Authority
MC
Monaco
Prior art keywords
weight
coating
pyridoxine hcl
doxylamine succinate
minutes
Prior art date
Application number
MC2486A
Other languages
English (en)
French (fr)
Inventor
Eric Gervais
Original Assignee
Duchesnay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42104724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC200059(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Duchesnay Inc filed Critical Duchesnay Inc
Publication of MC200059A1 publication Critical patent/MC200059A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seal Device For Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Power Steering Mechanism (AREA)
  • Lubricants (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MC2486A 2000-12-20 2002-06-20 Formulation à délai d'action rapide MC200059A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002350195A CA2350195C (en) 2000-12-20 2000-12-20 Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US09/885,051 US6340695B1 (en) 2000-12-20 2001-06-21 Rapid onset formulation
PCT/CA2001/000951 WO2003000263A1 (en) 2000-12-20 2001-06-21 Rapid onset formulation

Publications (1)

Publication Number Publication Date
MC200059A1 true MC200059A1 (fr) 2003-01-30

Family

ID=42104724

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2486A MC200059A1 (fr) 2000-12-20 2002-06-20 Formulation à délai d'action rapide

Country Status (34)

Country Link
US (1) US6340695B1 (da)
EP (1) EP1397133B1 (da)
JP (1) JP4242763B2 (da)
KR (1) KR100527985B1 (da)
CN (1) CN1229112C (da)
AT (1) ATE307582T1 (da)
AU (1) AU2001272243B2 (da)
BE (1) BE1014929A4 (da)
BR (1) BR0107371A (da)
CA (1) CA2350195C (da)
DE (2) DE60114475T2 (da)
DK (2) DK1397133T3 (da)
EG (1) EG24483A (da)
ES (1) ES2251494T3 (da)
FI (1) FI117961B (da)
FR (1) FR2826277B1 (da)
GB (1) GB2383751C (da)
GR (1) GR1004371B (da)
HU (1) HU227003B1 (da)
IL (1) IL150349A0 (da)
IS (1) IS2225B (da)
IT (1) ITTO20020524A1 (da)
LU (1) LU90934B1 (da)
MC (1) MC200059A1 (da)
MX (1) MXPA02006037A (da)
MY (1) MY132786A (da)
NL (1) NL1020895C2 (da)
NO (1) NO332190B1 (da)
PL (1) PL204507B1 (da)
SE (1) SE526307C2 (da)
TR (1) TR200201685T1 (da)
UA (1) UA74807C2 (da)
UY (1) UY27352A1 (da)
WO (1) WO2003000263A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US8012506B2 (en) * 2001-04-10 2011-09-06 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
US8257746B2 (en) 2001-04-10 2012-09-04 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
ES2229876B1 (es) * 2001-06-26 2006-03-01 Duchesnay Inc. Formulacion de accion rapida.
CA2392486A1 (en) * 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JP2004231520A (ja) * 2003-01-28 2004-08-19 Nichiko Pharmaceutical Co Ltd 保存安定性及び溶出速度に優れた医薬組成物
US20050004181A1 (en) * 2003-07-03 2005-01-06 Duchesnay Inc. Use of anti-emetic for pre and post operative care
CA103771S (en) 2003-07-22 2006-01-18 Duchesnay Inc Pharmaceutical dosage form
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
RU2445092C2 (ru) * 2005-04-28 2012-03-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Композиция, содержащая средство против деменции
US20070277530A1 (en) * 2006-05-31 2007-12-06 Constantin Alexandru Dinu Inlet flow conditioner for gas turbine engine fuel nozzle
CN102108059B (zh) * 2010-09-03 2012-05-09 合肥工业大学 一种琥珀酸多西拉敏的合成方法
US8950188B2 (en) 2011-09-09 2015-02-10 General Electric Company Turning guide for combustion fuel nozzle in gas turbine and method to turn fuel flow entering combustion chamber
NZ627593A (en) * 2012-02-22 2015-12-24 Duchesnay Inc Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
WO2013172297A1 (ja) 2012-05-14 2013-11-21 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤
NZ716017A (en) 2013-07-22 2020-07-31 Duchesnay Inc Composition for the management of nausea and vomiting
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
CN103432126A (zh) * 2013-08-05 2013-12-11 北京阜康仁生物制药科技有限公司 一种治疗孕吐的药物组合物
US9526703B2 (en) 2014-08-29 2016-12-27 Duchesnay Inc. Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
SG11201701448XA (en) * 2014-08-29 2017-03-30 Duchesnay Inc Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
CA2995431A1 (en) 2015-08-17 2017-02-23 Aequus Pharmaceuticals Inc. Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride
CN105510512B (zh) * 2016-01-25 2018-06-29 南京济群医药科技股份有限公司 一种琥珀酸多西拉敏有关物质的rt-hplc检测方法
RS61368B1 (sr) * 2018-09-27 2021-02-26 Inibsa Ginecologia S A Postupak za pripremu višejediničnog oralnog doznog oblika sa modifikovanim oslobađanjem doksilamin sukcinata i piridoksin hidrohlorida
CN114099450A (zh) * 2020-08-31 2022-03-01 长春海悦药业股份有限公司 一种比拉斯汀片及其制备方法
AU2021225255B1 (en) * 2021-09-03 2022-06-16 Patel, Mihir MR Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting.
CN118638044A (zh) * 2023-03-13 2024-09-13 南京济群医药科技股份有限公司 一种快速释放的琥珀酸多西拉敏组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085641A1 (en) * 1970-04-20 1971-12-31 Investigations Sci Pharm Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
DE69216642T2 (de) * 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
CA2139896C (en) * 1995-01-10 2000-03-28 Don B. Mcdonah Use of antinauseant agent for terminally ill humans
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
CN100391438C (zh) * 1999-09-14 2008-06-04 史密丝克莱恩比彻姆公司 制备水性包被小球粒的方法
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate

Also Published As

Publication number Publication date
SE0202061L (sv) 2003-01-28
MY132786A (en) 2007-10-31
ES2251494T3 (es) 2006-05-01
DE60114475D1 (de) 2005-12-01
US6340695B1 (en) 2002-01-22
LU90934B1 (fr) 2002-12-23
EP1397133B1 (en) 2005-10-26
FI20021708A0 (fi) 2002-09-25
KR20030023612A (ko) 2003-03-19
WO2003000263A1 (en) 2003-01-03
FR2826277A1 (fr) 2002-12-27
GB0213990D0 (en) 2002-07-31
DK176018B1 (da) 2005-12-05
GB2383751B (en) 2005-02-09
HUP0301950A3 (en) 2005-06-28
MXPA02006037A (es) 2005-05-12
GB2383751A (en) 2003-07-09
FI117961B (fi) 2007-05-15
IS2225B (is) 2007-04-15
GR20020100280A (el) 2003-03-28
JP4242763B2 (ja) 2009-03-25
CN1447694A (zh) 2003-10-08
GB2383751C (en) 2008-08-05
NO20022982L (no) 2002-10-09
NO332190B1 (no) 2012-07-23
DE10196426T1 (de) 2003-08-21
KR100527985B1 (ko) 2005-11-09
IE20020488A1 (en) 2003-04-30
PL362763A1 (en) 2004-11-02
AU2001272243B2 (en) 2004-02-05
UA74807C2 (en) 2006-02-15
HK1052654A1 (en) 2003-09-26
CA2350195A1 (en) 2001-08-11
SE526307C2 (sv) 2005-08-16
TR200201685T1 (tr) 2003-06-23
HUP0301950A2 (hu) 2003-11-28
UY27352A1 (es) 2002-09-30
DE60114475T2 (de) 2006-07-13
JP2004521146A (ja) 2004-07-15
DK200200947A (da) 2003-01-03
BR0107371A (pt) 2003-06-10
SE0202061D0 (sv) 2002-07-03
NO20022982D0 (no) 2002-06-20
DK1397133T3 (da) 2006-02-27
ITTO20020524A0 (it) 2002-06-18
NL1020895C2 (nl) 2003-03-13
FR2826277B1 (fr) 2004-07-02
ATE307582T1 (de) 2005-11-15
IL150349A0 (en) 2003-12-23
ITTO20020524A1 (it) 2003-12-18
CA2350195C (en) 2003-06-10
EG24483A (en) 2009-08-09
HU227003B1 (en) 2010-04-28
PL204507B1 (pl) 2010-01-29
FI20021708L (fi) 2002-12-22
EP1397133A1 (en) 2004-03-17
IS6412A (is) 2002-12-22
BE1014929A4 (fr) 2004-06-01
CN1229112C (zh) 2005-11-30
GR1004371B (el) 2003-10-23
NL1020895A1 (nl) 2002-12-30

Similar Documents

Publication Publication Date Title
BE1014929A4 (fr) Formulation a delai d'action rapide.
TWI326602B (en) Guaifenesin sustained release formulation and tablets
TWI241188B (en) Sertraline salts and sustained-release dosage forms of sertraline
TWI409064B (zh) Pharmaceutical composition
RU2456989C2 (ru) Твердые лекарственные формы, содержащие тадалафил
JP2931409B2 (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
JPH02209A (ja) カルビドパ／レボドパの制御放出配合剤
TW200803831A (en) Solid pharmaceutical compositions containing pregabalin
JPH01250314A (ja) 徐放性製剤
TW200819128A (en) Extended release gastro-retentive oral drug delivery system for valsartan
JPS6354319A (ja) 放出制御カルビド−パ／レボド−パ配合剤
CN111840239B (zh) 一种普瑞巴林缓释制剂
JP2009543885A (ja) イブプロフェンの投与のための方法および医薬
JP2004143175A (ja) 薬物の経口投与用徐放性組成物
WO2010046932A2 (en) Extended release pharmaceutical composition of minocycline and process thereof
JP2010536798A (ja) 難溶性薬物の生体利用率を制御するための方法及び組成物
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
CN106456611B (zh) 用于治疗恶心、呕吐或腹泻症状的恩丹西酮缓释固体制剂
TWI883162B (zh) 一種非布司他片
EP1512394A1 (en) Universal controlled-release composition comprising chitosan
WO2003011256A1 (en) Oral controlled release pharmaceutical composition of a prokinetic agent
JP5245175B2 (ja) 持続放出型錠剤の製造方法
JPH11180875A (ja) テオフィリン徐放性錠剤及びその製造方法
CN1172429A (zh) 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
EP1465607A1 (fr) Compositions pharmaceutiques a liberation modifiee